Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients

AIMS: Vedolizumab (VDZ) prevents migration of activated leucocytes into inflamed mucosa. This study aimed to assess the patterns of serum cytokines in ulcerative colitis (UC) patients at baseline and during VDZ treatment, and to investigate their association with mucosal healing and clinical remissi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Clin Pharmacol
Main Authors: Bertani, Lorenzo, Baglietto, Laura, Antonioli, Luca, Fornai, Matteo, Tapete, Gherardo, Albano, Eleonora, Ceccarelli, Linda, Mumolo, Maria Gloria, Pellegrini, Carolina, Lucenteforte, Ersilia, de Bortoli, Nicola, Bellini, Massimo, Marchi, Santino, Blandizzi, Corrado, Costa, Francesco
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7319004/
https://ncbi.nlm.nih.gov/pubmed/32027388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14235
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados